gynecologist-icon
Endometriosis
I had endometrioma 2 - 3 years ago it resolved by itself . Last week on a routine Usg hemorrhagic follicles appeared of size 15 and 13 mm I took follihair AM PM tablet, can it be cause for the recurring endometriosis?? I took it just for 8 days It had some plant protein named soy isoflavolone My doubt is that 8 days of supplement can cause it??
12 Views v

Answers (1)

A hemorrhagic follicle is not the same thing as an endometrioma. It is a normal ovarian cyst that forms when a follicle bleeds after ovulation, and sizes like 15mm and 13mm are common. Most settle on their own within a cycle or two, so this is unlikely to be your endometrioma recurring. An 8 day course of Follihair, even with soy isoflavone in it, is very unlikely to have caused this. That short a course does not carry enough hormonal effect to trigger it.
Next Steps
A repeat pelvic ultrasound after your next period, around day 2 to 5, will show whether the follicle has resolved on its own, which is what usually happens.
Health Tips
See your gynaecologist sooner if you get sudden one sided pelvic pain, heavy bleeding, or the follicle is still there or has grown on your next scan.
Answered
Flag this Answer
Flag this answer
1/1 people found this helpful
Was this answer helpful?
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.